Alto Ingredients vs Aemetis
ALTO and AMTX side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALTO and AMTX compare
Alto Ingredients is the larger company, worth 3.4 times as much as Aemetis ($285M against $85.2M).
Alto Ingredients grew revenue faster over the last twelve months (1.1% versus −1.7% for Aemetis).
Alto Ingredients keeps more of each dollar of sales as profit, with a net margin of 5.5% compared with −27.4% at Aemetis.
Alto Ingredients scores higher on the StockData Score (13 against 4 for Aemetis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALTO | AMTX |
|---|---|---|
| Size and price | ||
| Market cap | $285M | $85.2M |
| Share price | $3.68 | $1.18 |
| Change, 1 year | 89.7% | −39.5% |
| Change, 5 years | −27.1% | −93.3% |
| Beta (5Y) | −1.13 | −2.72 |
| Employees | 390 | 220 |
| StockData Score | ||
| Total score | 13 (better) | 4 |
| Valuation score | 4 (better) | 1 |
| Growth score | 2 | 2 |
| Performance score | 3 (better) | 1 |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 5.6× | – |
| P/S | 0.3× (better) | 0.4× |
| P/B | 1.1× | – |
| EV/EBITDA | 5.3× | – |
| P/FCF | 5.7× | – |
| FCF yield | 17.5% (better) | −46.2% |
| Fair value | $14.01 | – |
| Margin of safety | 73.7% | – |
| Growth | ||
| Revenue growth (TTM) | 1.1% (better) | −1.7% |
| Revenue growth, 5Y average | 0.46% | 3.6% (better) |
| Profitability | ||
| Gross margin | 6.8% | 10.9% (better) |
| Operating margin | 3.8% (better) | −5.3% |
| Net margin | 5.5% (better) | −27.4% |
| FCF margin | 5.3% (better) | −17.9% |
| Return on equity | 22.2% | – |
| Return on invested capital | 9.5% (better) | −12.5% |
| Financial health | ||
| Debt / equity | 0.23 | – |
| Net debt / EBITDA | 0.60 | – |
| Interest coverage | 3.8× (better) | −0.2× |
| Current ratio | 3.19 (better) | 0.08 |
| Altman Z-score | 1.44 (better) | −4.12 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | −28.0% |
| Shareholder yield | 0.00% (better) | −28.0% |
| Ownership | ||
| Held by institutions | 46.3% | 24.5% |
| Held by insiders | 9.2% | 10.9% |
| Insider net buying, 12 months | $361K (better) | −$20.5K |
| Short interest, % of float | 7.0% | 13.1% |
Go deeper
- ALTO stock overview
- ALTO income statement
- ALTO valuation and score
- AMTX stock overview
- AMTX income statement
- AMTX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.